Leef Brands, Inc. (LEEF.CX)
0.285
0.00 (0.00%)
CAD |
CNSX |
Aug 25, 16:00
Leef Brands Total Liabilities (Quarterly) : 77.25M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 77.25M |
| March 31, 2026 | 66.43M |
| December 31, 2025 | 61.23M |
| September 30, 2025 | 80.26M |
| June 30, 2025 | 74.17M |
| March 31, 2025 | 74.42M |
| September 30, 2024 | 61.51M |
| June 30, 2024 | 60.98M |
| March 31, 2024 | 62.59M |
| December 31, 2023 | 59.35M |
| September 30, 2023 | 54.99M |
| June 30, 2023 | 42.50M |
| March 31, 2023 | 50.93M |
| December 31, 2022 | 46.33M |
| September 30, 2022 | 40.04M |
| January 31, 2022 | 11.65M |
| October 31, 2021 | 11.61M |
| July 31, 2021 | 12.64M |
| April 30, 2021 | 3.365M |
| Date | Value |
|---|---|
| January 31, 2021 | 3.405M |
| October 31, 2020 | 3.058M |
| July 31, 2020 | 7.285M |
| April 30, 2020 | 1.789M |
| January 31, 2020 | 13.49M |
| October 31, 2019 | 13.37M |
| July 31, 2019 | |
| April 30, 2019 | 0.4926M |
| January 31, 2019 | 0.1525M |
| October 31, 2018 | 0.0645M |
| July 31, 2018 | 0.0465M |
| April 30, 2018 | 0.0419M |
| January 31, 2018 | 0.0353M |
| October 31, 2017 | 0.0737M |
| July 31, 2017 | 0.9082M |
| April 30, 2017 | 0.8889M |
| January 31, 2017 | 0.8464M |
| October 31, 2016 | 0.8415M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| NeutriSci International, Inc. | -- |
| Jamieson Wellness, Inc. | 677.34M |
| Vitality Products, Inc. | 2.29M |
| Genix Pharmaceuticals Corp. | 1.583M |
| LSL Pharma Group, Inc. | 65.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 74.36M |
| Shareholders Equity (Quarterly) | -2.894M |
| Debt to Equity Ratio | -6.090 |
| Current Ratio | 2.128 |
| Net Debt Paydown Yield | 4.20% |